LINC00624 获得性增强通过破坏组蛋白去乙酰化酶 6/含三重基序蛋白 28/锌指蛋白 354C 辅抑制复合物促进肝癌进展
本研究在肝细胞癌中鉴定出位于 chr1q21.1、源自 CHD1L 反义链的长链非编码 RNA LINC00624。LINC00624 过表达在体内外增强肿瘤生长和转移,机制上通过加速 HDAC6 泛素化降解并抑制 TRIM28 三聚体形成,破坏 HDAC6-TRIM28-ZNF354C 转录辅抑制复合物,解除对 CHD1L 和 BCL9 启动子的转录抑制。作者认为 LINC00624 可作为 HCC 的潜在治疗靶点。
要点
- LINC00624 位于 chr1q21.1,源自 CHD1L 反义链,在 HCC 中拷贝数增加且转录激活。
- LINC00624 过表达在体内外增强肿瘤生长和转移。
- LINC00624 破坏 HDAC6-TRIM28-ZNF354C 复合物,解除对 CHD1L 和 BCL9 的转录抑制。
核心结论
- LINC00624 作为分子诱饵将 HDAC6-TRIM28-ZNF354C 转录辅抑制复合物隔离在特定基因组位点之外,可能成为 HCC 的潜在治疗靶点。
研究设计与样本
- 研究在肝细胞癌中鉴定位于 chr1q21.1、源自 CHD1L 反义链的长链非编码 RNA LINC00624,并进行体外和体内功能与机制实验。
主要发现
- LINC00624 过表达在体外和体内增强肿瘤生长和转移。
- LINC00624 高水平增强 HDAC6 与 TRIM28 的相互作用,加速 HDAC6 泛素化与降解。
- LINC00624 结合 TRIM28 的 RBCC 结构域,抑制三聚体形成,并减弱 TRIM28 与 ZNF354C 的相互作用。
- LINC00624 过表达破坏 HDAC6-TRIM28-ZNF354C 转录辅抑制复合物形成,使复合物从 CHD1L 和 BCL9 启动子解离,从而解除转录抑制。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Long noncoding RNAs (lncRNAs) are involved in almost every stage of tumor initiation and progression. Here, we have identified an antisense lncRNA, LINC00624, that arises from the antisense strand of chromo-domain-helicase-DNA-binding protein 1-like (CHD1L), located on chr1q21.1, with significant copy number gain and transcriptional activation of CHD1L and B-cell CLL/lymphoma 9 protein (BCL9), in hepatocellular carcinoma (HCC). APPROACH AND RESULTS: Overexpression of LINC00624 enhances tumor growth and metastasis in vitro and in vivo. Mechanistically, higher levels of LINC00624 strengthen the interaction between histone deacetylase 6 (HDAC6) and tripartite motif containing 28 (TRIM28), which accelerates HDAC6 ubiquitination and degradation. Moreover, LINC00624 binds to the RBCC domain of TRIM28, inhibits trimer formation, and weakens the interaction between TRIM28 and zinc finger protein 354C (ZNF354C). Thus, LINC00624 overexpression disrupts the formation of the HDAC6-TRIM28-ZNF354C transcriptional corepressor complex, resulting in the dissociation of the complex from the promoter of CHD1L and BCL9, thereby removing transcription inhibition. CONCLUSIONS: Our findings suggest that LINC00624 acts as a molecular decoy that sequesters the HDAC6-TRIM28-ZNF354C transcriptional corepressor complex away from the specific genomic loci, and that it can potentially be a therapeutic target in HCC.
引用
- Li Z, Lu X, Liu Y, et al. Gain of LINC00624 Enhances Liver Cancer Progression by Disrupting the Histone Deacetylase 6/Tripartite Motif Containing 28/Zinc Finger Protein 354C Corepressor Complex. Hepatology. 2021. PMID: 32869873. doi:10.1002/hep.31530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。